cisplatin-pemetrexed
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for cisplatin-pemetrexed, covering 2021-12-21 to 2024-04-23. Get the full timeline:
Most recent: Clinical Trial Update: JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations [Phase 3]